Why We Like Herbalife Nutrition Ltd.’s (NYSE:HLF) 37% Return On Capital Employed
Today we’ll evaluate Herbalife Nutrition Ltd. (NYSE:HLF) to determine whether it could have potential as an investment… …read more […]
Today we’ll evaluate Herbalife Nutrition Ltd. (NYSE:HLF) to determine whether it could have potential as an investment… …read more […]
Some have more dollars than sense, they say, so even companies that have no revenue, no profit, and a record of… …read more […]
Berkshire Hathaway is on its fourth year without making a major acquisition. …read more […]
Nissan ex-boss Carlos Ghosn will hold a news conference in Beirut on Jan. 8, a lawyer for Ghosn said on Wednesday, two days after abruptly arriving from Japan, where he was under house arrest and accused of financial misconduct.
Bob Iger became the CEO of The Walt Disney Company (NYSE:DIS) in 2005. This analysis aims first to contrast CEO… …read more […]
Drugmakers including Bristol-Myers Squibb Co, Gilead Sciences Inc, and Biogen Inc hiked U.S. list prices on more than 50 drugs on Wednesday, bringing total New Year’s Day drug price increases to more than 250, according to data analyzed by healthcare research firm 3 Axis Advisors. Reuters reported on Tuesday that drugmakers including Pfizer Inc, GlaxoSmithKline PLC and Sanofi SA were planning to increase prices on more than 200 drugs in the United States on Jan. 1. …read more […]
Drugmakers including Bristol-Myers Squibb Co, Gilead Sciences Inc, and Biogen Inc hiked U.S. list prices on more than 50 drugs on Wednesday, bringing total New Year’s Day drug price increases to more than 250, according to data analyzed by healthcare research firm 3 Axis Advisors.
Drugmakers including Bristol-Myers Squibb Co, Gilead Sciences Inc, and Biogen Inc hiked U.S. list prices on more than 50 drugs on Wednesday, bringing total New Year’s Day drug price increases to more than 250, according to data analyzed by healthcare research firm 3 Axis Advisors. Reuters reported on Tuesday that drugmakers including Pfizer Inc, GlaxoSmithKline PLC and Sanofi SA were planning to increase prices on more than 200 drugs in the United States on Jan. 1. …read more […]
How far off is Groupon, Inc. (NASDAQ:GRPN) from its intrinsic value? Using the most recent financial data, we’ll take… …read more […]
While some investors are already well versed in financial metrics (hat tip), this article is for those who would like… …read more […]
The trade union representing cabin crew at Lufthansa’s budget airline Germanwings decided on Wednesday not to continue their strike for the time being after three days of stoppages led to dozens of flights being canceled.
Fugitive former Nissan chairman Carlos Ghosn met Lebanon’s president after his escape from Japan, where he was smuggled out of house arrest by a private security company, two sources close to Ghosn said on Wednesday.
Rich Fairbank became the CEO of Capital One Financial Corporation (NYSE:COF) in 1994. This analysis aims first to… …read more […]
Bruce Van Saun became the CEO of Citizens Financial Group, Inc. (NYSE:CFG) in 2013. This report will, first, examine… …read more […]
Today we’ll take a closer look at Intuit Inc. (NASDAQ:INTU) from a dividend investor’s perspective. Owning a strong… …read more […]
Copyright 1997-2019 Wall Street Reporter / Octagon Media Corp.